Drug Discovery

Pain killers
#Drug development #Ensysce Biosciences #Opioids #Painkillers #Public health

In Conversation With: Dr Lynn Kirkpatrick, Ensysce Biosciences

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Dr Lynn Kirkpatrick, CEO… Read More

#News

Conference microphone
#AI / data analytics / healthtech / informatics #Biotherapeutics #Events #Lab technology #SLAS2024

SLAS2024 update: How tech is reducing failure rates in trials

Be sure to attend the Ignite Theater at SLAS2024 in Boston on 5 and 6 February 2024. Focused on the theme ‘Innovation & technology: from lab to patient’, the DDW-curated programme, sponsored by Integra Biosciences and Hamamatsu Corporation, will feature presentations from experts… Read More

#News

Marine Diatom colony
#Biotechnology #DNA #Drug discovery #Genetics / genomics #Microbiology

World’s largest catalogue of ocean DNA could boost drug discovery

The world’s most comprehensive database for understanding microbial distribution and function in the ocean has been released, opening up new opportunities for drug discovery. Scientists at the King Abdullah University of Science and Technology (KAUST) in Thuwal, Saudi Arabia used the KAUST Metagenomic Analysis Platform (KMAP)… Read More

#News

Precision medicine
#Drug discovery #Funding #Precision medicine #Sano Genetics #Software

$11.4m raised to power a ‘precision medicine revolution’  

Sano Genetics, a software company working to accelerate precision medicine research, has raised $11.4 million in new funding, led by Plural with participation from existing investors including MMC Ventures, Episode 1 and Seedcamp.   Sano Genetics is developing software which combines genetic testing, recruitment, and long-term engagement in… Read More

#Business & Investment #News

Conference microphone
#AI / data analytics / healthtech / informatics #Biotherapeutics #Events #Lab technology #SLAS2024

SLAS2024 update: New tech accelerates drug development

The SLAS Ignite Theater ‘Innovation & technology: from lab to patient’, co-sponsored by Integra Biosciences and Hamamatsu Corporation, will take place at SLAS2024 in Boston on 5 and 6 February 2024. Developed by DDW in partnership with SLAS, the programme will feature leading… Read More

#News

amino acids chain
#Biologics #Drug discovery #Infographic #Nanomedicine / nanotechnology #Proteins

Compare methods for thermal stability assessment of proteins

A new infographic ‘Four methods for thermal stability assessment of therapeutic proteins‘ is now available to download for free. Thermal stability is among the most common critical quality attributes (CQAs) used for early developability assessment of biologics. In this infographic, learn about four methods for thermal stability… Read More

#News

#Biologics #Drug discovery #Infographic #Nanomedicine / nanotechnology #Proteins

Four methods for thermal stability assessment of proteins

Thermal stability is among the most common critical quality attributes (CQAs) used for early developability assessment of biologics. In this infographic, learn about four methods for thermal stability assessment of proteins – what they measure, what the data tells you, and their benefits and limitations. While each provides unique value,… Read More

#Intelligence #Resources

#AI / data analytics / healthtech / informatics #Epidemiology #Events #Lab technology #SLAS2024

Connecting academia, industry and the public

Erin Welsh, PhD, is a disease ecologist and epidemiologist now working full-time as a science communicator. Erin Allmann Updyke, MD, PhD is an epidemiologist and disease ecologist currently in a medical residency programme to complete her training. Together, they make up This Podcast Will Kill You. Ahead of being a… Read More

#Exclusive Content

Boston
#AI / data analytics / healthtech / informatics #Events #Lab technology #SLAS2024

Join DDW for the SLAS2024 Ignite Theater ‘Innovation from lab to patient’

SLAS2024 International Conference and Exhibition takes place in Boston, USA, on 3-7 February. DDW will be hosting two conference tracks highlighting expertise in the lab to patient process. In a new feature for SLAS2024, DDW will be hosting a programme of presentations at the Ignite Theater located in the exhibition… Read More

#Exclusive Content

Boston skyline
#AI / data analytics / healthtech / informatics #Events #Lab technology #SLAS2024

Innovation at every turn: Hello SLAS2024

Ahead of SLAS2024 on 3-7 February, in Boston, Jill Hronek, SLAS Director, Marketing & Communications, reflects on what to expect. SLAS is excited to be back in Boston for the 2024 International Conference and Exhibition. Our theme – Innovation at Every Turn – is multifaceted. It speaks to the almost… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Lab technology #SLAS2024

Where is the Ignite Theater tech leading us?

At this year’s SLAS event, DDW has curated a track taking place in the Ignite Theater. Sponsored by Integra Biosciences and Hamamatsu Corporation, it will explore technologies being used for drug discovery and how they get from lab to patient. Megan Thomas explains. Dipanwita Das, CEO of Sorcero, is the… Read More

#Exclusive Content

#Cancer #Diagnostics #Drug discovery #Oncology #Precision medicine

Can liquid biopsies transform precision medicine?

Brett Swansiger, Chief Commercial Officer at ANGLE, discusses the importance of liquid biopsies in precision medicine trials for cancer.   Challenges in the oncology clinical trials space The oncology market is a key growth driver for the pharma industry, with global drug revenues expected to reach US$390 billion by… Read More

#Cancer Research #Exclusive Content

Scientific technology
#AI / data analytics / healthtech / informatics #Clinical development #Data automation #Data management #Diagnostics #Drug discovery #Electronic Lab Notebooks (ELN) #FAIR Principles #Genomics #Immunology / Virology & Vaccines #Infectious diseases #Informatics #mRNA #Personalised medicine #Precision medicine #Predictive diagnostics #Public health

New podcast: Revolutionary technology for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Revolutionary technology for drug discovery and development” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: mRNA technology may hold the future for a cytomegalovirus vaccine; … Read More

#News

Business financing
#Drug discovery #Financing #Obesity #Phase I trial #Resalis Therapeutics

€10M financing to support disease-modifying obesity drug

Italy-based Resalis Therapeutics has closed a €10 million ($11 million) Series A financing round led by Sunstone Life Science Ventures with participation from existing investors. The company intends to use the proceeds to initiate and complete the first-in-human Phase I clinical trial and reach Phase II… Read More

#Business & Investment #News

#Biopharmaceuticals #Clarivate #Drug development #Drug discovery #Market reporting

Thirteen potential blockbuster drugs to watch in 2024

Thirteen new-to-market therapeutics and drugs poised to launch in 2024 will achieve ‘blockbuster’ status by 2029 or deliver game-changing benefits to patients. They include therapeutics for conditions including breast cancer, haemophilia A, sickle cell disease, Crohn’s disease, ulcerative colitis, respiratory syncytial virus (RSV) and multiple myeloma, among… Read More

#News #Trending News #Trends & Analysis